医学
生殖系
腺癌
种系突变
肿瘤科
内科学
肺
肺癌
突变
癌症研究
遗传学
癌症
基因
生物
作者
Kelsey Pan,Jennifer Owens,Yasir Y. Elamin,Charles Lu,Mark J. Routbort,Jianjun Zhang,Frank V. Fossella,Marcelo V. Negrão,Mehmet Altan,Jenny Vu Pozadzides,Ferdinandos Skoulidis,Anne S. Tsao,Tina Cascone,John V. Heymach,Edwin J. Ostrin,Xiuning Le
标识
DOI:10.1016/j.jtho.2024.06.004
摘要
Germline mutations driving lung cancer have been infrequently reported in literature, with EGFR T790M being a known germline mutation identified in 1% of NSCLC. Typically, a somatic EGFR mutation is acquired to develop lung adenocarcinoma. Osimertinib has become standard-of-care treatment for EGFR T790M-positive lung cancer.
科研通智能强力驱动
Strongly Powered by AbleSci AI